These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9541411)

  • 21. Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction.
    Olson ST; Srinivasan KR; Björk I; Shore JD
    J Biol Chem; 1981 Nov; 256(21):11073-9. PubMed ID: 7287752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysine 114 of antithrombin is of crucial importance for the affinity and kinetics of heparin pentasaccharide binding.
    Arocas V; Bock SC; Raja S; Olson ST; Bjork I
    J Biol Chem; 2001 Nov; 276(47):43809-17. PubMed ID: 11567021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
    Fan B; Turko IV; Gettins PG
    Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin.
    Preissner KT; Müller-Berghaus G
    J Biol Chem; 1987 Sep; 262(25):12247-53. PubMed ID: 2442161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.
    Pimenta DC; Nantes IL; de Souza ES; Le Bonniec B; Ito AS; Tersariol IL; Oliveira V; Juliano MA; Juliano L
    Biochem J; 2002 Sep; 366(Pt 2):435-46. PubMed ID: 12000310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
    Björk I; Ylinenjärvi K; Olson ST; Bock PE
    J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.
    Lormeau JC; Herault JP; Herbert JM
    Thromb Haemost; 1996 Jul; 76(1):5-8. PubMed ID: 8819242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement.
    Streusand VJ; Björk I; Gettins PG; Petitou M; Olson ST
    J Biol Chem; 1995 Apr; 270(16):9043-51. PubMed ID: 7721817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the antithrombin III heparin binding site.
    Ersdal-Badju E; Lu A; Zuo Y; Picard V; Bock SC
    J Biol Chem; 1997 Aug; 272(31):19393-400. PubMed ID: 9235938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of arginine 129 in heparin binding and activation of antithrombin.
    Desai U; Swanson R; Bock SC; Bjork I; Olson ST
    J Biol Chem; 2000 Jun; 275(25):18976-84. PubMed ID: 10764763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of lysine 125 for heparin binding and activation of antithrombin.
    Schedin-Weiss S; Desai UR; Bock SC; Gettins PG; Olson ST; Björk I
    Biochemistry; 2002 Apr; 41(15):4779-88. PubMed ID: 11939772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysine residue 114 in human antithrombin III is required for heparin pentasaccharide-mediated activation.
    Kridel SJ; Knauer DJ
    J Biol Chem; 1997 Mar; 272(12):7656-60. PubMed ID: 9065421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III.
    Schoen P; Wielders S; Petitou M; Lindhout T
    Thromb Res; 1990 Feb; 57(3):415-23. PubMed ID: 2315894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of a reducing-end extension on pentasaccharide binding by antithrombin.
    Belzar KJ; Dafforn TR; Petitou M; Carrell RW; Huntington JA
    J Biol Chem; 2000 Mar; 275(12):8733-41. PubMed ID: 10722716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic studies on chemically synthesized pentasaccharide and tetrasaccharide fragments.
    Choay J
    Semin Thromb Hemost; 1985 Apr; 11(2):81-5. PubMed ID: 4035368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High affinity interaction between a synthetic, highly negatively charged pentasaccharide and alpha- or beta-antithrombin is predominantly due to nonionic interactions.
    Hjelm R; Schedin-Weiss S
    Biochemistry; 2007 Mar; 46(11):3378-84. PubMed ID: 17323934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-dimensional affinity resolution electrophoresis demonstrates that three distinct heparin populations interact with antithrombin III.
    Edens RE; Fromm JR; Fromm SJ; Linhardt RJ; Weiler JM
    Biochemistry; 1995 Feb; 34(8):2400-7. PubMed ID: 7873519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombin 'DREUX' (Lys 114Glu): a variant with complete loss of heparin affinity.
    Mushunje A; Zhou A; Huntington JA; Conard J; Carrell RW
    Thromb Haemost; 2002 Sep; 88(3):436-43. PubMed ID: 12353073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin binding domain peptides of antithrombin III: analysis by isothermal titration calorimetry and circular dichroism spectroscopy.
    Tyler-Cross R; Sobel M; Marques D; Harris RB
    Protein Sci; 1994 Apr; 3(4):620-7. PubMed ID: 8003980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.